At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 20 enrolled
Drug / intervention
CPL-01 +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Phase 2a, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Pharmacokinetic Profile of CPL-01 in the Management of Acute Postoperative Pain After Mini-abdominoplasty Surgery
In Brief
A Phase 2 clinical trial evaluating CPL-01 and Placebo for Abdominoplasty. Completed, enrolled 20 participants across 1 site.
Detailed Summary
Evaluate the Safety and Pharmacokinetic Profile of CPL-01 in patients after mini-abdominoplasty
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAbdominoplasty
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
2020202120222023202420252026
First PostedDec 2019
Enrollment StartJan 2020
Primary CompletionFeb 2020
TodayJul 2026
First PostedDec 2, 2019
Enrollment StartJan 6, 2020
Primary CompletionFeb 28, 2020
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 6.6 years ago
Interventions
CPL-01drug
CPL-01 will be administered
Placebodrug
Placebo will be administered